Cases & Deals

Purdue Pharma successfully resolves Hatch-Waxman patent infringement claims against Ascent related to OxyContin®

Clients Purdue Pharma L.P.

Jones Day successfully represented Purdue Pharma L.P. in related Hatch-Waxman patent infringement actions against defendant Ascent Pharmaceuticals, Inc., pertaining to the submission of an Abbreviated New Drug Application to the FDA seeking approval of a generic version of OxyContin®. Purdue came to a successful resolution of the dispute through settlement.

Purdue Pharma LP et al. v. Ascent Pharmaceuticals, Inc., Nos. 1-18-cv-00083, -00855 (D. Del.)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.